NVDA

188.62

+1.1%↑

AVGO.US

347.51

+0.39%↑

ORCL

195.59

+0.37%↑

MU

315.2

+10.35%↑

CSCO

76.03

-1.26%↓

NVDA

188.62

+1.1%↑

AVGO.US

347.51

+0.39%↑

ORCL

195.59

+0.37%↑

MU

315.2

+10.35%↑

CSCO

76.03

-1.26%↓

NVDA

188.62

+1.1%↑

AVGO.US

347.51

+0.39%↑

ORCL

195.59

+0.37%↑

MU

315.2

+10.35%↑

CSCO

76.03

-1.26%↓

NVDA

188.62

+1.1%↑

AVGO.US

347.51

+0.39%↑

ORCL

195.59

+0.37%↑

MU

315.2

+10.35%↑

CSCO

76.03

-1.26%↓

NVDA

188.62

+1.1%↑

AVGO.US

347.51

+0.39%↑

ORCL

195.59

+0.37%↑

MU

315.2

+10.35%↑

CSCO

76.03

-1.26%↓

Search

Amplitude Inc

Gesloten

SectorTechnologie

10.94 -5.53

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.87

Max

11.61

Belangrijke statistieken

By Trading Economics

Inkomsten

682K

-24M

Verkoop

5.3M

89M

EPS

0.02

Winstmarge

-27.083

Werknemers

800

EBITDA

6.5M

-21M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+29.53% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

266M

1.6B

Vorige openingsprijs

16.47

Vorige sluitingsprijs

10.94

Nieuwssentiment

By Acuity

50%

50%

126 / 403 Rangschikking in Technology

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Amplitude Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 dec 2025, 22:20 UTC

Belangrijke Marktbewegers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec 2025, 17:31 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec 2025, 16:30 UTC

Belangrijke Marktbewegers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec 2025, 15:19 UTC

Belangrijke Marktbewegers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec 2025, 15:17 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec 2025, 14:37 UTC

Belangrijke Marktbewegers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 jan 2026, 23:35 UTC

Marktinformatie

Gold Rises Amid Geopolitical Risks -- Market Talk

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope Sold Stake in JV to Tata Steel

1 jan 2026, 21:28 UTC

Acquisities, Fusies, Overnames

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 jan 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:13 UTC

Acquisities, Fusies, Overnames

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec 2025, 20:40 UTC

Marktinformatie

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec 2025, 20:22 UTC

Marktinformatie

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec 2025, 19:50 UTC

Marktinformatie

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec 2025, 19:31 UTC

Marktinformatie

Precious Metals Cap Off Record Runs -- Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec 2025, 17:17 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec 2025, 17:16 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

31 dec 2025, 17:00 UTC

Acquisities, Fusies, Overnames

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec 2025, 15:57 UTC

Acquisities, Fusies, Overnames

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec 2025, 15:54 UTC

Marktinformatie

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec 2025, 15:02 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec 2025, 14:40 UTC

Acquisities, Fusies, Overnames

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec 2025, 14:20 UTC

Marktinformatie

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec 2025, 13:46 UTC

Marktinformatie

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Vergelijking

Prijswijziging

Amplitude Inc Prognose

Koersdoel

By TipRanks

29.53% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15 USD  29.53%

Hoogste 18 USD

Laagste 13 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Amplitude Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Technische score

By Trading Central

9.395 / N/ASteun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Neutral Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

126 / 403 Rangschikking in Technologie

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Amplitude Inc

Amplitude, Inc., together with its subsidiaries, provides a digital analytics platform that analyzes customer behavior in the United States and internationally. It offers Amplitude Analytics, which provides real-time product data and reconstructed user visits; Amplitude Experiment, a solution that allows teams to test new capabilities and safely roll out new features; Amplitude CDP, an insight-driven solution that encompasses the data infrastructure, audience management, and data streaming capabilities; and Amplitude Session Replay used by product, marketing, and data teams to understand user behavior, diagnose product issues, and improve product outcomes. The company also provides customer support services related to initial implementation setup, ongoing support, and application training. It delivers its application over the Internet as a subscription service using a software-as-a-service model. The company was formerly known as Sonalight, Inc. and changed its name to Amplitude, Inc. in December 2014. Amplitude, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.
help-icon Live chat